Suppliers / Kumar Organic Products

Kumar Organic Products

India Updated 9 July 2026

Kumar Organic Products is an API manufacturer based in India. It holds 5 active US drug master files across a filed portfolio of 3 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 August 2025 as VAI. Customs aggregates show $21.8M of exports covering 677 molecules to 53 destinations in 2025.

5
active US DMFs
0
valid CEPs
7
registered plants 3 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 22 August 2025 VAI US FDA
  • 13 June 2025 VAI US FDA
  • 21 April 2023 VAI US FDA
  • 14 November 2019 OAI US FDA
  • 8 February 2019 VAI US FDA
  • 20 July 2018 NAI US FDA
  • 22 September 2016 VAI US FDA
  • 13 May 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Vadodara, India 3009167769
Hassan, India Not on file
hassan 573 201, India Not on file
Bangalore, India 3003768909
Hassan, India 3008957541
bengaluru 560 105, India Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Ciclopirox US FDA 3
Minoxidil SFDA (Saudi Arabia), US FDA 3
Triclosan US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) None 4
US FDA None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $3.5M 31
2025 Not reported $21.8M 53
2024 Not reported $17.1M 50
2023 Not reported $18.7M 46

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Kumar Organic Products comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 22 August 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts